CHI Logo
Shop
Checkout
Header Graphic
September 8, 2010
| Insight Pharma Reports > All Reports
ALL REPORTS

Loading...

Corporate Subscription Program

Insight Pharma Reports has developed and maintained a very impressive and loyal client base, including senior level executives, global competitive intelligence executives, librarians, information specialists, and research scientists.

Click here for more info
Add to Del.icio.us Add to digg Add to Connotea Add to Facebook Add to LinkedIn EMail Page Printer Friendly Book Mark

2007 Reports:

Loading...

The following reports are published and available for immediate shipment.

 

Please contact Al Doig at adoig@healthtech.com to suggest topics to be updated or new topics to be covered in the area of pharmaceutical drug discovery and development.

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Table of Contents | Tables and Figures | Executive Summary

Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Backup Compound Strategies: Best Practices for Reducing Phase II Risk
Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Table of Contents | Tables and Figures | Executive Summary
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

High-Content Analysis: Technologies, Applications, Market Analysis
High-Content Analysis: Technologies, Applications, Market Analysis
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Table of Contents | Tables and Figures | Executive Summary

Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
March 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Table of Contents | Tables and Figures | Executive Summary

Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary
2006 Reports
Outlook for Predictive Safety Technologies
November 2006
Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Comparative Genomic Hybridization: Current State and Future Directions
September 2006
Proteomics: Current State and Future Directions
September 2006
Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Microdosing in Translational Medicine: Pros and Cons
May 2006
Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
The Impact of Genomics on Clinical Trials and Medical Practice
April 2006
Multiplex Assays: Technologies, Applications, and Markets
April 2006
Oncogenomics: The Future of Cancer Cure
January 2006
All Reports 2010 - 2009 - 2008 - 2007 - 2006 - 2005

Cambridge Healthtech Institute

Footer Image
Loading...
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com